Chromatin Dynamics and Genome Regulation
Chromatin Dynamics and Genome Regulation
批准号:
10386668
负责人:
Laura Banaszynski
金额:
$4.1万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-04 至 2022-07-31
关键词:
Amino AcidsBindingBiochemistryBiologyCellsCellular StructuresChemicalsChildhood GlioblastomaChromatinDataDepositionDevelopmentDiseaseEmbryoGene ActivationGenomeGenomic SegmentGenomicsHistonesHomeostasisHumanIslet Cell TumorMalignant NeoplasmsMediatingMolecular ChaperonesMutateMutationNucleosomesPhysiologyPost-Translational Protein ProcessingPropertyProteinsPublic HealthRegulationRegulatory ElementResearchResearch ProposalsRoleSystemTherapeuticVariantcell typeepigenetic regulationgenomic locushistone modificationinnovationinsightinterestmouse geneticsprogramstranscription factor
中文摘要
在哺乳动物发育过程中,染色质的动态调节允许
一个基因组中有超过200种不同的细胞除了翻译后修饰
选择性地将组蛋白变体掺入染色质中,
表观遗传调控的复杂性。例如,组蛋白变体H3.3不同于典型的H3
只有4 - 5个氨基酸,但显示出独特的基因组和发育富集
特性.虽然长期以来与基因激活有关,但最近的研究表明,H3.3
在不同的基因组区域中的多种功能并不总是与活性相关,
染色质状态人类H3.3及其相关蛋白突变的鉴定
癌症,包括小儿胶质母细胞瘤和胰腺神经内分泌肿瘤,
强调了迫切需要了解这种组蛋白变体在发育过程中的作用,
上下文尽管越来越感兴趣,H3.3如何独特地促进染色质的功能
是一个长期悬而未决的问题我们提出了一个创新的方案
结合小鼠遗传学、生物化学、化学生物学和尖端基因组学,
了解H3.3介导的染色质动力学的功能相关性。我们的中央
假设H3.3沉积促进了独特的发育
调节染色质景观,允许做出适当的细胞命运决定。我们
初步数据表明核小体更新速率在没有H3.3的情况下降低,
并且H3.3动力学可以促进组蛋白在特定的翻译后修饰状态,
基因组区域。在我们的研究过程中,我们将(1)定义潜在的机制
H3.3在促进特定组蛋白翻译后修饰状态中的功能,(2)鉴定
控制H3.3在特定基因组位点沉积的调节机制,
组蛋白变体在两个已知伴侣系统之间的分布,以及(3)确定
染色质动力学在谱系特异性转录因子的能力中的重要性,
在早期胚胎的细胞命运转变过程中结合靶调控元件。我们提出的
这项研究意义重大,因为它将确定染色质变异体是
细胞命运的转变,并作为一个平台,以了解细胞身份的表观遗传调控
在体内平衡,以及发育失调和疾病状态中。
英文摘要
Dynamic regulation of chromatin during mammalian development allows the specification of
over 200 different cell types from a single genome. In addition to post-translational modification
of histone proteins, selective incorporation of histone variants into chromatin adds to the
complexity of epigenetic regulation. For example, histone variant H3.3 differs from canonical H3
by only 4-5 amino acids, yet displays distinct genomic and developmental enrichment
properties. While long associated with gene activation, recent studies suggest that H3.3 has
multiple functions in distinct genomic regions that are not always correlated with an active
chromatin state. The identification of mutations in H3.3 and associated proteins in human
cancers, including pediatric glioblastomas and pancreatic neuroendocrine tumors, has
heightened the pressing need to understand the role of this histone variant in a developmental
context. Despite increased interest, how H3.3 contributes uniquely to the function of chromatin
is a long-standing, unanswered question in the field. We propose an innovative program
combining mouse genetics, biochemistry, chemical biology, and cutting-edge genomics to
understand the functional relevance of H3.3-mediated chromatin dynamics. Our central
hypothesis is that H3.3 deposition promotes the establishment of unique developmentally
regulated chromatin landscapes that allow appropriate cell fate decisions to be made. Our
preliminary data suggests that nucleosome turnover rates are reduced in the absence of H3.3,
and that H3.3 dynamics may facilitate histone post-translational modification states at specific
genomic regions. Over the course of our studies we will (1) define the mechanisms underlying
H3.3 function in promoting specific histone post-translational modification states, (2) identify
regulatory mechanisms that control deposition of H3.3 at specific genomic loci, and the
distribution of the histone variant between the two known chaperone systems, and (3) determine
the importance of chromatin dynamics in the ability of lineage-specific transcription factors to
bind target regulatory elements during cell fate transitions in the early embryo. Our proposed
research is significant because it will establish chromatin variants as necessary components of
cell fate transitions, and serve as a platform to understand epigenetic regulation of cell identity
in both homeostasis, but also developmental misregulation and disease states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of p300 Activation During Pluripotency and Differentiation.
-
批准号:10685500
-
项目类别:
-
资助金额:$42.04万
-
财政年份:2022
-
负责人:Laura Banaszynski
-
依托单位:
Chromatin Dynamics and Genome Regulation
-
批准号:10226117
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2017
-
负责人:Laura Banaszynski
-
依托单位:
Chromatin Dynamics and Genome Regulation
-
批准号:9973224
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2017
-
负责人:Laura Banaszynski
-
依托单位:
Chromatin Dynamics and Genome Regulation
-
批准号:10406225
-
项目类别:
-
资助金额:$50.99万
-
财政年份:2017
-
负责人:Laura Banaszynski
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: